Bodewes, F.A.

study group period breath subject range treatment lipase patient infant run-in period triglyceride breath test pancreatic fi brosis randomized event lipase /kg pancrease mt enzyme children randomization run-in treatment groups visit palatability 30 months intake gastroenterology study medication study period safety therapy triglyceride dosage pancreatic enzyme therapy brosi parent university hospital antwerp result activity number pancrease treatment group baseline lipase activity randomization period university breath samples 1000- sample medication hospital 1500- absorption 500- malabsorption month diagnosis microtablet fi brosing colonopathy pancrelipase microtablets baseline period 2000- lipase /kg dose subjects ages 6 weight /kg treatment group pancreatic enzymes phase ii randomized cf-related pi pancrelipase parallel-group pilot study analysis pediatr bottle department volume efficacy nutrition compliance